The Section of Infectious Diseases at Rush University Memorial Hospital has provided Chicagoans with high-quality HIV/AIDS care since 1984, while concurrently growing its reputation as a top research institution.
"We look at effectiveness, availability, and what's trending," said Craig Johnson, community health promoter at Rush. "The doctors and researchers here are really on top of what's new and what's next."
A special focus is studying historically under-represented at-risk populations, said Johnson. "If we know that a broader number of African Americans, Latinos, and women are getting infected, but that number is not getting more involved in research, then we're looking at a disparity in the pool," he noted. "When others are trending down, why are these groups going up?" Other research has looked at gender and racial differences in the efficacy of certain medicines.
The hospital works with community partners such as the South Side Help Center and the Black Treatment Advocates Network to recruit research participants. Johnson stresses that patients who enroll in clinical trials receive antiretroviral medication plus supplemental medical care.
To learn more about clinical trials at Rush, visit www.rush.edu.
Back to other news for March 2012
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy